Neuralink is Elon Musk’s brain-computer interface company, and as of January 2026 it had 21 participants enrolled in human trials worldwide. It implanted its first human in January 2024, raised $650 million in June 2025 at a reported $9 billion pre-money valuation, and is now working on Blindsight, a vision-restoring implant.
Welcome to Alux.com, the place where future billionaires come to get inspired. If you want the story faster, here is the video:
| Date | Milestone |
|---|---|
| 2016 | Neuralink founded |
| August 2020 | Pig demonstration with Gertrude, Dorothy and Joyce |
| May 2023 | Approved for US human trials |
| January 2024 | First human implant announced |
| September 2024 | Blindsight receives FDA breakthrough designation |
| June 2025 | $650 million Series E at about $9 billion pre-money |
| August to October 2025 | First patients in Canada and the UK |
| January 2026 | 21 participants enrolled worldwide |
1. What Is Neuralink and What Does It Do?
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of eight scientists and engineers, based in Fremont, California. It develops implantable brain-computer interfaces (BCIs) that read signals from the brain and turn them into commands for a computer.
The first product, called Telepathy, is designed to help people with paralysis control a computer or phone with their thoughts. The long-term goal is far bigger, which Musk has described as a kind of symbiosis with artificial intelligence.
2. It Has Moved From Pigs to People
For years Neuralink was a promise. In 2019 it had received $158 million in funding, about $100 million of it from Musk, and it anticipated human experiments in 2020. That slipped to 2023, and the company was approved for human trials in the United States in May 2023.
On January 29, 2024, Musk announced that the first human had been implanted the day before. The patient was later identified as Noland Arbaugh, who is quadriplegic and reported being able to control a computer cursor with the implant.
3. The Trial Is Growing Worldwide
As of September 2025, Musk reported 12 trial participants with over 2,000 cumulative days and 15,000 hours of use. In January 2026, Neuralink said it had 21 participants enrolled worldwide.
In August and September 2025, Toronto’s University Health Network performed Canada’s first Neuralink surgeries on two patients with cervical spinal cord injuries, the first outside the United States. In October 2025, University College London announced that Paul, the first UK patient, had successfully controlled a computer with the implant.
4. Blindsight Aims to Restore Vision
Neuralink’s second product, Blindsight, is meant to let blind people whose visual cortex is undamaged regain some level of vision. Musk said in March 2024 that it was working in monkeys at low resolution that was expected to improve.
The US Food and Drug Administration granted Blindsight “breakthrough device” designation in September 2024, a status that is meant to speed up development.
5. The Money Behind It
Neuralink raised $650 million in a Series E round in June 2025, reportedly at a pre-money valuation of about $9 billion. At the end of 2025 Musk said the company would begin “high-volume production” and move toward an almost entirely automated surgical procedure in 2026.
These are company targets, and timelines at Neuralink have slipped before, so treat them as aims rather than guarantees.
6. A Sewing Machine for the Brain
The implant is placed by a surgical robot, often described as a sewing machine, that inserts ultra-thin, flexible threads into the brain. Its needle is just 25 micrometers wide, and it can insert up to six wires (192 electrodes) per minute.
The current implant has 1,024 electrodes across 64 threads and is fully wireless. The robot is designed to avoid blood vessels, because the procedure is too delicate for human hands alone.
7. The Founding Team Has Changed
Neuralink was founded by Max Hodak, Benjamin Rapoport, Dongjin Seo, Paul Merolla, Philip Sabes, Tim Gardner, Tim Hanson and Vanessa Tolosa, working with Musk. Most have since left: Hodak announced he no longer worked with the company in May 2021, and only two of the eight co-founders remained as of January 2022.
Rapoport, a neurosurgeon, left in 2018 and later founded Precision Neuroscience, which uses surface electrodes instead of penetrating ones. Musk is listed as Neuralink’s chief executive officer in Tesla’s October 2026 proxy statement.
8. The Timeline Keeps Slipping
In 2019 Neuralink hoped to begin human experiments in 2020. It took until 2024. Scientists had warned that Musk was underestimating how long safety and efficacy testing would take, and the pattern shows how slow medical technology is compared with software.
As Nelson Mandela is often quoted as saying, it always seems impossible until it’s done. The honest summary is that the technology works for a small number of people, and scaling it will take years of evidence.
9. The Pig Demo of 2020
In August 2020 Musk showed off the technology using three pigs. Joyce had no device, Gertrude had a coin-sized device recording neurons connected to her snout, and Dorothy had one implanted and later removed to show the process is reversible.
The demo proved the device could read and interpret brain signals in real time. It was a showpiece, and the real tests came with human participants.
10. Ethics, Privacy and Security
Putting a computer in the brain raises hard questions. Who owns the data that comes from your brain? Who can access it? What happens to it when you die? How secure is a wireless implant against hackers?
Medical regulators approve trials step by step, but laws around neural data are still catching up. These are questions to ask before anyone volunteers.
11. Competition Is Growing
Neuralink is not alone. Precision Neuroscience, founded by former Neuralink co-founder Rapoport, takes a different, less invasive route, and the field is attracting a growing number of university labs and start-ups.
Neuroscientists give mixed assessments of Neuralink. Some praise its high channel count and wireless design. Others note that its electrodes still record groups of neurons rather than individual ones.
12. Challenges That Remain
Neuralink must develop materials that stay safe in the brain without infections or deterioration, read data quickly at high resolution, and handle huge volumes of signal data. In May 2024 Musk even asked the public for help with a compression challenge, saying a ratio of more than 200x was needed.
Co-founder Rapoport said that safety concerns influenced his decision to leave in 2018, and the company has faced criticism over its pace and culture. Those risks are part of any frontier technology.
13. What Could It Cost?
Musk was vague when asked about price, saying early on it might cost a few thousand dollars including surgery and hoping that over time the price would approach that of laser eye surgery or consumer electronics. That is a hope, not a price list.
For now, participants join clinical trials rather than buying the device.
14. Musk’s Vision of Merging With AI
Musk has said since 2016 that humans could end up as pets to AI unless we connect our brains to computers. Neuralink, he says, would let humans compete with AI. He expects a “closer merger of biological intelligence and digital intelligence” over time.
Critics argue that merging with AI could diminish the human brain. The debate has only grown as AI itself has advanced, and it connects to the question of how AI changes wealth and work.
15. Memory and Telepathy Are Still Science Fiction
Early talk of “consensual telepathy” and saving and replaying memories is exciting, and Musk has said the future is going to be weird. But today’s device works for movement and control, not for reading thoughts or storing memories.
If memory replay ever happens, it will raise even more questions about privacy and identity. For now, it remains an idea.
16. Would You Get One?
Aluxers, the technology that once looked like a pitch is now helping real people with spinal cord injuries operate computers. Whether it grows into a mass-market device or stays a medical tool is still open.
Would you ever consider getting a chip in your brain? Would you store and replay memories if you could? Let us know.
Keep reading
- How the AI Gold Rush is Making People Rich: the money side of the AI boom
- Are We In An AI Bubble?: the risk side of the same story
FAQ
What is Neuralink?
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of eight scientists and engineers to build implantable brain-computer interfaces. Its first product, Telepathy, lets people with paralysis control devices with their thoughts.
Has Neuralink been implanted in a human?
Yes. On January 29, 2024, Musk announced the first human implant, later identified as Noland Arbaugh. By January 2026, Neuralink said it had 21 participants enrolled in trials worldwide.
What is Blindsight?
Blindsight is Neuralink’s second product, aimed at restoring some vision in blind people whose visual cortex is undamaged. The FDA granted it breakthrough device designation in September 2024.
How much money has Neuralink raised?
By 2019 it had raised $158 million. In June 2025 it raised a $650 million Series E, reportedly at a pre-money valuation of about $9 billion.
Can you buy a Neuralink?
No. It is available only to participants in clinical trials. Musk has said he hopes the price will eventually come down to that of laser eye surgery, but there is no public price.
Is Neuralink safe?
The trials are early, and long-term safety data is limited. Regulators approve each step, and the company says it is working on safe materials and a robotic surgery process. Ask a doctor about any medical device.
How we put this list together
We checked each claim against company announcements, regulatory designations and reporting on Neuralink’s trials as of October 2026. Where a figure is a company goal, a reported estimate or a statement by Musk, we say so.
Last updated: October 2026.